# Emergent Biosolutions LLC (NYSE: EBS), Canton, MA – FDA Inspections

Source: https://www.keypedia.com/companies/emergent-biosolutions-llc/a4e71e63-5d44-4dd7-a589-a755c72b0637

> Inspection records and compliance data for Emergent Biosolutions LLC in Canton, Massachusetts. 6 FDA inspections on record, 2 Form 483s, last inspected February 10, 2026. Publicly traded as NYSE: EBS.

---

## Details

- Name: Emergent Biosolutions LLC
- FEI Number: 3004051669
- Address Line 1: 50/90 Shawmut Rd
- City: Canton
- State: Massachusetts
- Zip Code: 02021
- Country Name: United States
- Address: 50/90 Shawmut Rd, Canton, Massachusetts 02021, United States
- Country: United States

## Stock

- Stock ticker: EBS
- Exchange: NYSE
- Share price: $5.88
- Market cap: $302.3M
- Price as of: November 13, 2026

## Related Documents

- FDA Inspection 1309368 - Emergent Biosolutions LLC - 2026-02-10 — source: FDA, date: February 10, 2026
- FDA Inspection 1309368 - Emergent Biosolutions LLC - 2026-02-10 — classification: No Action Indicated (NAI), source: FDA, date: February 10, 2026
- [483 - Emergent Biosolutions LLC - 2023-08-16](https://www.keypedia.com/records/483/emergent-biosolutions-llc/d7d52447-f29c-4a6b-a2c9-99be41ce1ae0) — source: FDA, date: August 16, 2023
- [FDA Inspection 1215398 - Emergent Biosolutions LLC - 2023-08-16](https://www.keypedia.com/records/fda_inspections/emergent-biosolutions-llc/7e0d6b89-ba46-4b43-95ee-f5abeac8e754) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 16, 2023
- [EIR - Emergent Biosolutions LLC - 2017-12-21](https://www.keypedia.com/records/eir/emergent-biosolutions-llc/85e7ae64-cb02-4d25-92ec-1380d382bada) — source: FDA, date: December 21, 2017
- [483 - Emergent Biosolutions LLC - 2017-12-21](https://www.keypedia.com/records/483/emergent-biosolutions-llc/878d4eff-86a9-4383-84fd-d7d5a3ccde2f) — source: FDA, date: December 21, 2017
- [FDA Inspection 1041003 - Emergent Biosolutions LLC - 2017-12-21](https://www.keypedia.com/records/fda_inspections/emergent-biosolutions-llc/6634790c-8b42-4709-b647-7e5bca2597bd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 21, 2017
- FDA Inspection 830320 - Emergent Biosolutions LLC - 2013-05-02 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 2, 2013
- FDA Inspection 684124 - Emergent Biosolutions LLC - 2010-09-22 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 22, 2010
- FDA Inspection 544784 - Emergent Biosolutions LLC - 2008-10-15 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 15, 2008

## Related Companies

- [Sarepta Therapeutics Inc](https://www.keypedia.com/companies/sarepta-therapeutics-inc/5a8d2168-ec04-4530-a81f-00bab06c4a44)
- [Juno Therapeutics Inc, a subsidiary of Bristol-Myers Squibb](https://www.keypedia.com/companies/juno-therapeutics-inc-a-subsidiary-of-bristol-myers-squibb/fff03cc2-ba14-4ac1-b81c-88b6bebad784)
- [GlaxoSmithKline Vaccines S.r.l.](https://www.keypedia.com/companies/glaxosmithkline-vaccines-srl/cddb07b7-c8a6-4dbd-a92c-c6ebeeb7e009)
- [Haematologic Technologies, LLC dba Prolytix](https://www.keypedia.com/companies/haematologic-technologies-llc-dba-prolytix/03297ca5-f207-401a-8202-1b343903beed)
- [North American Science Associates, LLC](https://www.keypedia.com/companies/north-american-science-associates-llc/9d289339-3edc-4d2e-aacb-4d849335e75d)
- [2seventy Bio, Inc.](https://www.keypedia.com/companies/2seventy-bio-inc/ba94f53c-26e4-479f-85c2-15a64583947d)
- [University of Massachusetts Incorporated](https://www.keypedia.com/companies/university-of-massachusetts-incorporated/a9ec28fe-9d2a-4259-8967-78eda631a711)
- [Nelson Laboratories, LLC](https://www.keypedia.com/companies/nelson-laboratories-llc/978675b0-9c60-4e40-9336-6a71b9f79805)
- [Diagnostic Services of Kansas State, Inc.](https://www.keypedia.com/companies/diagnostic-services-of-kansas-state-inc/a7fbc4c5-149a-43fe-8e45-6fe8b884c976)
- [Valneva Austria GmbH](https://www.keypedia.com/companies/valneva-austria-gmbh/66194b1b-2f22-4c17-bf51-36477cf94c61)

## Related Officers

- [Biologist](https://www.keypedia.com/people/joan-l-lu-primon/d97fb20f-b5af-4b5c-9c29-2c7ba96f197a)
- [Strategic Expert at NovoNordisk; Retired from FDA](https://www.keypedia.com/people/debra-m-emerson/58bd7fac-28eb-4369-b149-13a24cc00cf7)
- [company_representative](https://www.keypedia.com/people/tammy-lucik/26878225-a7a6-4ac4-bd9f-a1a26ab204a7)
- [recipient](https://www.keypedia.com/people/kristine-marchant/58e5bc49-fd7e-4667-89c0-bbc4104095fa)
- [Investigator](https://www.keypedia.com/people/shafiq-s-ahadi/dd146b0a-ca1c-4052-8f50-4d68e14ad73f)
- [Lewis K. Antwi](https://www.keypedia.com/people/lewis-k-antwi/8ab4f1c7-8b5b-4556-98a4-6edc3bc49470)
